NCT06830980 Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
| NCT ID | NCT06830980 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gopalkumar Rakesh |
| Condition | Methamphetamine Use Disorders |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-03-11 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-03-11 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to learn more about how accelerated theta burst stimulation affects methamphetamine craving and brain activity. Theta burst stimulation is a unique transcranial magnetic stimulation (TMS) paradigm that is efficient and potent.
Eligibility Criteria
Inclusion Criteria: * Adults in the age group 18-65 years * Able to read and understand English * Able to provide informed consent * Diagnosed with HIV * History of current or previous Methamphetamine Use Disorder * Endorse craving for methamphetamine * Demonstrate an attentional bias for methamphetamine Exclusion Criteria: * Traumatic brain injury * h/o seizure disorder * h/o or current diagnosis of schizophrenia * intracranial metal shrapnel * previous adverse effects with TMS * sub-threshold consistency while performing behavioral tasks * lack of attentional bias to methamphetamine cues * a positive pregnancy test for female participants * abnormal brain MRI
Contact & Investigator
Gopalkumar Rakesh, MD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT06830980 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Methamphetamine Use Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06830980 currently recruiting?
Yes, NCT06830980 is actively recruiting participants. Contact the research team at psych_research@uky.edu, annette.garth@uky.edu for enrollment information.
Where is the NCT06830980 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT06830980 clinical trial?
NCT06830980 is sponsored by Gopalkumar Rakesh. The principal investigator is Gopalkumar Rakesh, MD at University of Kentucky. The trial plans to enroll 30 participants.